SCHEMBL1266528

SCHEMBL1266528

OC1CCC[CH]CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3029140 0.94 TSHR (0.59)
SCHEMBL1144330 0.94
SCHEMBL3027117 0.91 TSHR (0.56)
SCHEMBL3030514 0.88 TSHR (0.59)
SCHEMBL3021215 0.88 TSHR (0.59)
SCHEMBL3022718 0.88 TSHR (0.59)
SCHEMBL3033128 0.88 TSHR (0.59)
SCHEMBL2537154 0.85
SCHEMBL11067862 0.83 TSHR (0.53)
SCHEMBL11062425 0.83 TSHR (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117597408-A Optical cement, preparation method thereof, display screen and terminal equipment 华为技术有限公司 2024-02-23 CN claimed
WO-2023272500-A1 OPTICAL ADHESIVE, PREPARATION METHOD THEREFOR, DISPLAY SCREEN, AND TERMINAL DEVICE 华为技术有限公司 2023-01-05 WO claimed
EP-1817032-A2 MODULATORS OF MUSCARINIC RECEPTORS Vertex Pharmaceuticals Incorporated (US) 2007-08-15 EP claimed
US-20060287303-A1 Modulators of muscarinic receptors VERTEX PHARMACEUTICALS INCORPORATED 2006-12-21 US claimed
WO-2006058294-A2 MODULATORS OF MUSCARINIC RECEPTORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-06-01 WO claimed
US-20240168340-A1 CURABLE RESIN COMPOSITION FOR USE IN SEALING MATERIAL FOR FILM LIQUID CRYSTAL PANEL, AND FILM LIQUID CRYSTAL PANEL HAVING END SEALED BY SAID CURABLE RESIN COMPOSITION NOF CORPORATION (JP) 2024-05-23 US disclosed
WO-2024070847-A1 CURABLE RESIN COMPOSITION FOR USE IN SEALING MATERIAL FOR FILM LIQUID CRYSTAL PANEL, AND FILM LIQUID CRYSTAL PANEL HAVING END SEALED BY SAID CURABLE RESIN COMPOSITION 日油株式会社 2024-04-04 WO disclosed
US-11942353-B2 Adhesive tape for semiconductor processing and method for producing semiconductor device LINTEC CORPORATION (JP) 2024-03-26 US disclosed
CN-117677891-A Curable resin composition for use in sealing material for film liquid crystal panel, and film liquid crystal panel sealed at end portion with the curable resin composition 日油株式会社 2024-03-08 CN disclosed
CN-117645845-A Adhesive sheet for semiconductor processing and method for manufacturing semiconductor device 琳得科株式会社 2024-03-05 CN disclosed
CN-117645844-A Adhesive sheet for semiconductor processing and method for manufacturing semiconductor device 琳得科株式会社 2024-03-05 CN disclosed
CN-117597408-A Optical cement, preparation method thereof, display screen and terminal equipment 华为技术有限公司 2024-02-23 CN disclosed
EP-1375479-A1 PYRROLIDINE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME Eisai Co., Ltd. (JP) 2004-01-02 EP disclosed
US-20030129385-A1 Photocurable resin composition, finely embossed pattern-forming sheet, finely embossed pattern transfer sheet, optical article, stamper and method of forming finely embossed pattern DAI NIPPON PRINTING CO., LTD. (JP) 2003-07-10 US disclosed
EP-0367036-B1 SUBSTITUTED 3-AMINOSYDNONIMINES, PROCESS FOR THEIR PREPARATION AND THEIR USE CASSELLA Aktiengesellschaft (DE) 1992-04-29 EP disclosed
EP-0367036-A2 Substituted 3-aminosydnonimines, process for their preparation and their use CASSELLA Aktiengesellschaft (DE) 1990-05-09 EP disclosed
EP-0035228-B1 TETRAZOLE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF, AND ANTI-ULCER COMPOSITION CONTAINING THE SAME OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1985-01-02 EP disclosed
US-4435404-A ANTICOAGULANTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1984-03-06 US disclosed
US-4372953-A Tetrazole derivatives, and anti-ulcer composition containing the same OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1983-02-08 US disclosed
EP-0035228-A1 Tetrazole derivatives, process for the preparation thereof, and anti-ulcer composition containing the same OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1981-09-09 EP disclosed